PHAN CHAU TRINH UNIVERSITY
PHAN CHAU TRINH UNIVERSITY
Tuyển Sinh Đại Học
Admissions 2025
Connect with us on Zalo:

Contact Admission

Call Us:
Send your documents:
09 Nguyen Gia Thieu street, Dien Ban Dong ward, Da Nang city, Vietnam

International Collaboration

For any enquiries regarding international collaboration or Student Elective Programs, please contact us at:
Follow Us on Social Media
Follow us on social media for tips, news and updates about appling to Phan Chau Trinh University:

JAMA + AI Weekly Update OCTOBER 11, 2025

Trouble viewing this email? Read it Online

Alt content Advertisement
JAMA masthead

Weekly Update

October 11, 2025

In this week’s JAMA+ AI Conversations, we are celebrating the one-year anniversary of JAMA+ AI!

How will 2026 shape the world of AI in health? JAMA+ AI Editor in Chief Roy Perlis, MD, MSc, and Associate Editor Yulin Hswen, ScD, MPH, discuss in this special episode marking one year since the launch of JAMA+ AI.

Will 2026 be the year of real-world evidence that AI can actually improve patient care? Will the major challenges in bringing AI to the clinic begin to succumb to a flood of investment?

Learn more and listen to the podcast.

Editor’s Picks in this week’s JAMA+ AI: 

  • JAMA recently issued a call for submissions on behalf of the 13 JAMA Network journals, inviting original research manuscripts that explore the application of AI in clinical settings. Submissions should emphasize rigorous methodologies and validation to support informed medical practice. Read the Editor’s Note: “Artificial Intelligence Across the JAMA Network: A Call for Submissions.”
  • Model drift can reduce the reliability of clinical prediction models, particularly during health system disruptions. Regular monitoring and strong regulatory standards are essential to maintain accurate and effective model performance. Read this Invited Commentary published in JAMA Health Forum.
  • Can we predict chronic kidney disease after cisplatin treatment? Findings published in JAMA Oncology suggest that cisplatin treatment is associated with a predictable decrease in the eGFR rate and that patients with lower baseline kidney function are most likely to develop chronic kidney disease.

EDITOR'S NOTE

JAMA

What Will Next Year Bring for AI in Health?

Roy Perlis, MD, MSc

JAMA

Artificial Intelligence Across the JAMA Network: A Call for Submissions

T. Y. Alvin Liu, MD; Yulin Hswen, ScD; Robert O. Bonow, MD, MS; et al

Invited Commentary

JAMA Health Forum

Understanding Model Drift and Its Impact on Health Care Policy

Andrew Wong, MD, MS; Jeremy B. Sussman, MD, MS

Original Investigation

JAMA Oncology

Predicting Chronic Kidney Disease After Cisplatin Treatment Using Population-Level Data

Robert C. Grant, MD, PhD; Jiang Chen He, MEng; Ning Liu, PhD; et al

AUDIO

AI, Health Care, and What to Expect in 2026

See the whole story. Subscribe to JAMA Network on YouTube.

JAMA Network signature

Thank you for subscribing to JAMA Network email alerts. This message was sent to buiduytam1@gmail.com by updates@email.jamanetwork.com.

To update your contact information, change your email preferences, or unsubscribe, click here.

To ensure you always receive JAMA Network emails, add the email address updates@email.jamanetwork.com to your address book.

To unsubscribe by mail, contact:

JAMA Network
AMA Plaza
330 N Wabash Ave
Chicago, IL 60611
Or call (800) 621-8335.

facebook icon twitter icon linked in icon pinterest icon youtube icon instagram icon

©2025 American Medical Association. All rights reserved.
 

Advertisement

PCTU pctu Hội nghị khoa học